Liquidia Q1 Earnings Call Highlights
Key takeaways
- Liquidia Q1 Earnings Call Highlights Market Beat Mon, May 11, 2026 at 10:07 PM GMT+7 7 min read LQDA Liquidia logo Key Points Interested in Liquidia Corporation?
- Liquidia’s YUTREPIA launch is gaining momentum, with first-quarter net product sales rising to $129.9 million, up 44% sequentially from Q4 2025.
- The company posted its third straight quarter of improving profitability, including net income of $52.9 million and adjusted EBITDA of $71.2 million.
Liquidia Q1 Earnings Call Highlights Market Beat Mon, May 11, 2026 at 10:07 PM GMT+7 7 min read LQDA Liquidia logo Key Points Interested in Liquidia Corporation? Here are five stocks we like better.
Liquidia’s YUTREPIA launch is gaining momentum, with first-quarter net product sales rising to $129.9 million, up 44% sequentially from Q4 2025. The company said it had about 4,500 unique patient prescriptions and roughly 3,750 patients started on therapy since launch.
The company posted its third straight quarter of improving profitability, including net income of $52.9 million and adjusted EBITDA of $71.2 million. Liquidia ended the quarter with $222.8 million in cash, which management said supports continued investment without relying on capital markets.